P2X7: a growth-promoting receptor—implications for cancer

[1]  F. Di Virgilio,et al.  Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase , 2008, PloS one.

[2]  P. Pinton,et al.  Ca2+ signaling, mitochondria and cell death. , 2008, Current molecular medicine.

[3]  A. Surprenant,et al.  Pannexin-1 Couples to Maitotoxin- and Nigericin-induced Interleukin-1β Release through a Dye Uptake-independent Pathway* , 2007, Journal of Biological Chemistry.

[4]  A. Surprenant,et al.  Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor , 2006, The EMBO journal.

[5]  F. Di Virgilio,et al.  A role for P2X7 in microglial proliferation , 2006, Journal of neurochemistry.

[6]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[7]  L. Augenlicht,et al.  Growth properties of colonic tumor cells are a function of the intrinsic mitochondrial membrane potential. , 2006, Cancer research.

[8]  F. Di Virgilio,et al.  The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. , 2006, Cancer research.

[9]  T. Schulz,et al.  Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth , 2006, Journal of Biological Chemistry.

[10]  A. Surprenant,et al.  Pseudoapoptosis Induced by Brief Activation of ATP-gated P2X7 Receptors* , 2005, Journal of Biological Chemistry.

[11]  F. Di Virgilio,et al.  Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. , 2005, Molecular biology of the cell.

[12]  D. Hall,et al.  The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho , 2004, Journal of leukocyte biology.

[13]  M. Slater,et al.  Early prostate cancer detected using expression of non‐functional cytolytic P2X7 receptors , 2004, Histopathology.

[14]  Andrew J. Wilson,et al.  The intrinsic mitochondrial membrane potential (Deltapsim) is associated with steady-state mitochondrial activity and the extent to which colonic epithelial cells undergo butyrate-mediated growth arrest and apoptosis. , 2003, Cancer research.

[15]  Geoffrey Burnstock,et al.  Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. , 2003, The Journal of investigative dermatology.

[16]  F. Di Virgilio,et al.  Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. , 2003, Molecular biology of the cell.

[17]  F. Di Virgilio,et al.  P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. , 2002, Blood.

[18]  R. North.  Molecular physiology of P2X receptors. , 2002, Physiological reviews.

[19]  G. Rutter,et al.  Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  F. Di Virgilio,et al.  Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor* , 1999, The Journal of Biological Chemistry.

[21]  D. Ferrari,et al.  P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death , 1999, FEBS letters.

[22]  R. Coutinho-Silva,et al.  P2Z purinoceptor-associated pores induced by extracellular ATP in macrophages and J774 cells. , 1997, American journal of physiology. Cell physiology.

[23]  J. Rhodes,et al.  Covalent chemical events in immune induction: fundamental and therapeutic aspects. , 1996, Immunology today.

[24]  M. Sitkovsky,et al.  Murine T lymphocytes modulate activity of an ATP-activated P2Z-type purinoceptor during differentiation. , 1996, Journal of immunology.

[25]  F. Di Virgilio,et al.  An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. , 1996, Blood.

[26]  F. Di Virgilio,et al.  Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures. , 1996, Biochemical and biophysical research communications.

[27]  M. Sitkovsky,et al.  Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP. , 1990, The Journal of biological chemistry.

[28]  F. Di Virgilio,et al.  Responses of mouse lymphocytes to extracellular adenosine 5'-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP. , 1989, Journal of immunology.

[29]  J. Dornand,et al.  Extracellular ATP increases cytosolic free calcium in thymocytes and initiates the blastogenesis of the phorbol 12-myristate 13-acetate-treated medullary population. , 1987, Biochimica et biophysica acta.

[30]  G. DosReis,et al.  Purinergic modulation of T-lymphocyte activation: differential susceptibility of distinct activation steps and correlation with intracellular 3',5'-cyclic adenosine monophosphate accumulation. , 1986, Cellular immunology.

[31]  R. G. Kemp,et al.  Exogenous ATP enhances calcium influx in intact thymocytes. , 1985, Journal of immunology.

[32]  R. Denton,et al.  On the role of the calcium transport cycle in heart and other mammalian mitochondria , 1980, FEBS letters.

[33]  F. Di Virgilio,et al.  Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? , 2008, Endocrinology.

[34]  M. Slater,et al.  Differentiation between Cancerous and Normal Hyperplastic Lobules in Breast Lesions , 2004, Breast Cancer Research and Treatment.

[35]  F. Di Virgilio.  The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. , 1995, Immunology today.

[36]  S. Weinhouse.  On respiratory impairment in cancer cells. , 1956, Science.